| Product Code: ETC12962786 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In the Poland naltrexone buprenorphine market, imports experienced a notable growth trend from 2023 to 2024, with a growth rate of 14.4%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at 10.44%. This import momentum can be attributed to increasing demand for opioid addiction treatment medications and a stable market environment conducive to trade expansion.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Naltrexone Buprenorphine Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Naltrexone Buprenorphine Market Revenues & Volume, 2022 & 2032F |
3.3 Poland Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Poland Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Poland Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2022 & 2032F |
3.6 Poland Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2022 & 2032F |
3.7 Poland Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Poland Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2022 & 2032F |
3.9 Poland Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2022 & 2032F |
4 Poland Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about opioid addiction treatment |
4.2.2 Growing adoption of medication-assisted treatment (MAT) programs |
4.2.3 Government initiatives to address opioid crisis in Poland |
4.3 Market Restraints |
4.3.1 Strict regulations and restrictions on the use of naltrexone and buprenorphine |
4.3.2 Limited availability of healthcare professionals trained in MAT |
4.3.3 Stigma associated with addiction treatment in society |
5 Poland Naltrexone Buprenorphine Market Trends |
6 Poland Naltrexone Buprenorphine Market, By Types |
6.1 Poland Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2022 - 2032F |
6.1.3 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2022 - 2032F |
6.1.4 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2022 - 2032F |
6.1.5 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2022 - 2032F |
6.1.6 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2022 - 2032F |
6.1.7 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2022 - 2032F |
6.2 Poland Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2022 - 2032F |
6.2.3 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2022 - 2032F |
6.2.4 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2022 - 2032F |
6.2.5 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2022 - 2032F |
6.2.6 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2022 - 2032F |
6.3 Poland Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2022 - 2032F |
6.3.3 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2022 - 2032F |
6.3.4 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2022 - 2032F |
6.3.5 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2022 - 2032F |
6.3.6 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2022 - 2032F |
6.4 Poland Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.4.3 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2022 - 2032F |
6.4.4 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2022 - 2032F |
6.4.5 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2022 - 2032F |
6.4.6 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2022 - 2032F |
6.5 Poland Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2022 - 2032F |
6.5.3 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2022 - 2032F |
6.5.4 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2022 - 2032F |
6.5.5 Poland Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2022 - 2032F |
6.5.6 Poland Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2022 - 2032F |
7 Poland Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Poland Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Poland Naltrexone Buprenorphine Market Imports from Major Countries |
8 Poland Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of MAT programs implemented in Poland |
8.2 Percentage increase in prescription of naltrexone and buprenorphine |
8.3 Number of healthcare professionals trained in MAT in Poland |
9 Poland Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Poland Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2022 & 2032F |
9.2 Poland Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2022 & 2032F |
9.3 Poland Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Poland Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2022 & 2032F |
9.5 Poland Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2022 & 2032F |
10 Poland Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Poland Naltrexone Buprenorphine Market Revenue Share, By Companies, 2025 |
10.2 Poland Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here